Blue Owl Capital: Speculative But At A Bargain Price

The author added Blue Owl Capital (OWL) to their portfolio as a speculative valuation play after its shares fell nearly 50% over the past year. The author cites $319 billion in AUM and a diversified business model as support for earnings power, despite negative sentiment in private credit markets. OWL is described as trading at a discount to or near peers, with some growth expectations remaining.

Analysis

The key underwriting question is not whether AUM is growing, but how much of it is fee-earning, durable, and convertible into distributable earnings. AUM can rise while fundraising costs, slower deployment, weaker realizations, or credit markdowns pressure fee growth and investor confidence. Verify fee-paying AUM by strategy, fundraising and deployment trends, credit performance, and any balance-sheet exposure before treating the share-price decline as mispricing.

The contrarian case is that private-credit stress may be overstated: tighter bank lending can create opportunities for established private lenders. But the second-order risk cuts both ways—refinancing pressure and weaker borrower cash flows can raise defaults, impair marks, and slow distributions across the sector, weighing on fundraising even before losses are realized. Large alternative managers such as Ares, Blackstone, and Apollo are relevant competitive reference points, not automatic substitutes; compare their strategy mix and earnings sensitivity rather than headline AUM.

Near term, sentiment and sector flows may dominate. Over 1–3 months, earnings disclosures on fee-paying AUM, fundraising, deployment, and credit quality are the useful catalysts. Over 6–18 months, realized credit outcomes and the durability of fundraising will determine whether a lower valuation is an opportunity or a justified risk premium. The article provides no valuation inputs or operating detail sufficient to establish that the discount is attractive.

Key Decisions for Investors

• No trade solely on the reported share-price decline or total AUM. Treat a long as a speculative thesis, not a valuation conclusion, until fee-paying AUM and earnings conversion are verified.
• For investors seeking exposure, consider only a staged, small long after evidence that fee-paying AUM and fundraising remain resilient and credit quality is not deteriorating; avoid adding on price weakness alone.
• Watch the next company results and disclosures for fundraising, deployment, fee-related earnings, credit marks, and balance-sheet exposure. Deterioration in these measures would falsify the recovery thesis; stable or improving metrics alongside continued discounting would strengthen it.
• A relative-value long OWL versus a diversified alternative-manager peer basket is an alert, not a current recommendation: first establish comparable valuation, strategy mix, and earnings sensitivity. A broad short hedge could otherwise obscure company-specific performance.